Flagship Ventures Fund Iv General Partner Llc

Affiliations

  • at Evelo Biosciences Inc. (EVLO), 2023-07-13
  • Large Shareholder at Axcella Health Inc. (AXLA), 2022-10-17
  • Large Shareholder at Rubius Therapeutics Inc. (RUBY), 2021-03-23
  • Large Shareholder at Kaleido Biosciences Inc. (KLDO), 2021-02-10
  • Large Shareholder at Seres Therapeutics Inc. (MCRB), 2020-11-25
  • Large Shareholder, Director at Moderna Inc. (MRNA), 2020-08-20
  • Large Shareholder at Transmedics Group Inc. (TMDX), 2019-10-31
  • Large Shareholder at Syros Pharmaceuticals Inc. (SYRS), 2017-08-21
  • Large Shareholder at Eleven Biotherapeutics Inc. (EBIO), 2016-09-26
  • Large Shareholder at Editas Medicine Inc. (EDIT), 2016-08-15
  • Large Shareholder at T2 Biosystems Inc. (TTOO), 2014-08-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
EVLO $2.31 3,246,753 3,931,685 2023-07-11 Filing
EVLO $2.31 1,082,251 1,493,241 2023-07-11 Filing
EVLO $2.31 1,082,251 1,461,795 2023-07-11 Filing
AXLA $1.64 3,048,780 Large Shareholder 3,048,780 2022-10-13 Filing
AXLA $1.64 919,111 Large Shareholder 6,299,611 2022-10-13 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MRNA $70.18 10,746 Large Shareholder, Director 6,420,766 2020-05-22 Filing
MRNA $69.45 69,254 Large Shareholder, Director 6,431,512 2020-05-22 Filing
MRNA $70.18 56,406 Large Shareholder, Director 21,986,399 2020-05-22 Filing
MRNA $69.45 363,594 Large Shareholder, Director 22,042,805 2020-05-22 Filing
MRNA $72.44 367 Large Shareholder, Director 6,500,766 2020-05-21 Filing